AMR Action Fund

Sobre

The AMR Action Fund is a global life-sciences specialist dedicated to developing urgently needed antibiotics and antifungals against antimicrobial resistance. Backed by biopharmaceutical companies, foundations and development banks, it targets more than $1 billion of investment and aims to help bring two to four new antimicrobial therapies to patients by 2030.

Sectores

• Ciencias de la vida

Inversiones destacadas

• F2G
• BioVersys
• Vedanta Biosciences
• Antabio
• Peptilogics
• Centauri Therapeutics
• TenNor Therapeutics
• Telum Therapeutics
• Trellis Bioscience
• Elion Therapeutics

Inversores

• Henry SkinnerChief Executive Officer→
• Martin HeideckerChief Investment Officer→
• Junjun GaoPrincipal→
• Carly LevineSenior Associate→
• Henni-Karoliina RopponenVenture Associate→
• Isabella SantiVenture Associate→

Cómo contactarlos

https://www.amractionfund.com/investments/#radarForm